Tag: Eli Lilly
Eli Lilly’s diabetic drug Mounjaro marks full year in market with US$5B in sales
by Editor | Feb 7, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Mounjaro a diabetic drug by Eli Lilly, an American pharmaceutical company...
Read MoreLilly partners with Max Foundation to expand Verzenio access for breast cancer patients
by Editor | Jan 7, 2024 | AFRICAN & MIDDLE EAST NEWS, NGOs, Associations & Development Partners, Pharmaceuticals & Manufacturing | 0
KENYA—Eli Lilly and Company, an American pharmaceutical company, has announced that it will...
Read MorePharmaceutical giants capitalize on soaring obesity rates with revolutionary weight-loss drugs
by Editor | Nov 20, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Obesity rates in the United States have witnessed a relentless ascent for well over a...
Read MorePharma giants Eli Lilly and Novo Nordisk drive retail investor interest amid weight-loss drug success
by Editor | Nov 19, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Retail investor interest in Eli Lilly has soared to a more than two-year high following the...
Read MoreEli Lilly bolsters manufacturing efforts with multi-billion investment in German plant
by Editor | Nov 17, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
GERMANY – Eli Lilly, a leading pharmaceutical company, is intensifying its manufacturing efforts...
Read MoreFDA greenlights Eli Lilly’s Zepbound: A game-changer in weight loss medication landscape
by Editor | Nov 9, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — The Food and Drug Administration (FDA) has granted approval to Eli Lilly’s Zepbound, a...
Read MoreEli Lilly resolves Mounjaro supply issues, continues expansion amid surging demand
by Editor | Nov 5, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Eli Lilly has reported improvements in the supply of its popular diabetes drug, Mounjaro, in...
Read MoreEli Lilly makes strategic leadership changes in anticipation of FDA’s decision on Mounjaro
by Editor | Oct 6, 2023 | LATEST NEWS, People News, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — In the dynamic landscape of the pharmaceutical industry, Eli Lilly is poised for a...
Read MoreEli Lilly faces FDA setback as eczema drug application for Lebrikizumab is rejected
by Editor | Oct 3, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — The Food and Drug Administration (FDA) has declined Eli Lilly’s application for its...
Read MoreNICE recommends Eli Lilly’s Mounjaro for treating type 2 diabetes in a turnaround decision
by Editor | Sep 12, 2023 | Government, Regulatory & Policy News, LATEST NEWS, WORLD NEWS | 0
UNITED KINGDOM — In a surprising turn of events, the National Institute for Health and Care...
Read MoreMariana Oncology secures US$175 million in Series B round with Eli Lilly on board
by Editor | Sep 8, 2023 | LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0
FRANCE — Investors have demonstrated strong support for Mariana Oncology’s series B...
Read MoreAMPATH and Eli Lilly’s 20-year-long partnership continues to benefit many in Western Kenya with life-saving medications
by Editor | Aug 25, 2023 | AFRICAN & MIDDLE EAST NEWS, Hospitals, LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing | 0
KENYA – The Eli Lilly and Company (Lilly), a global healthcare leader, has continually supported...
Read More